The sale of antidepressants and mood elevators in India surged from Rs 1,540 crore in 2020 to Rs 2,536 crore by Nov 2024.

Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.

Depression and anxiety are among the most common complications of stroke. Is it time for new treatment guidance?

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

Selective serotonin reuptake inhibitors, or SSRIs, were the third class or generation of antidepressants developed. They are now the most commonly prescribed antidepressant medications. They are ...

Both drugs were given on top of standard antidepressants to patients wo had ... and the company will look to the new data to try to encourage take-up. One issue has been the cost of the drug ...

Botanists Name Beautiful New Species of 'Lipstick Vine' from the Philippine Rainforest Dec. 12, 2024 — Scientists have today announced the discovery of a species of lipstick vine completely new ...